Down-Regulation of Canonical and Up-Regulation of Non-Canonical Wnt Signalling in the Carcinogenic Process of Squamous Cell Lung Carcinoma

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Bartis, Domokos ^a,b   Csongei, Veronika ^a,c   Weich, Alexander ^a   Kiss, Edit ^a,c   Barko, Szilvia ^a   Kovacs, Tamas ^a,c   Avdicevic, Monika ^a   D'Souza, Vijay K ^b   Rapp, Judit ^a,c   Kvell, Krisztian ^a,c   Jakab, Laszlo ^a   Nyitrai, Miklos ^b,c   Molnar, Tamas F ^a   Thickett, David R ^b   Laszlo, Terezia ^a   Pongracz, Judit E ^a,c  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA ACTIN; BETA CATENIN; CADHERIN; CALVASCULIN; NERVE CELL ADHESION MOLECULE; UVOMORULIN; WNT11 PROTEIN; WNT5A PROTEIN;

ARTICLE; ASMA GENE; BETA ACTIN GENE; CONTROLLED STUDY; DOWN REGULATION; E CADHERIN GENE; FRIZZLED 3 GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; N CADHERIN GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; S100A4 GENE; VIM GENE; WNT SIGNALING PATHWAY; WNT11 GENE; WNT5A GENE;

BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84874699165     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057393     Document Type: Article

References (41)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002 Cancer J Clin. 55: 74-108.
2. Pongracz JE, Stockley RA, (2006) Wnt signaling in lung development and diseases. Respiratory Res 7: 15.
3. Calvo R, West J, Franklin W, Erickson P, Bemis L, et al. (2000) Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci USA 97: 12776-12781.
4. He B, You L, Uematsu K, Xu Z, Lee AY, et al. (2004) A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 6: 7-14.
5. You L, He B, Xu Z, Uematsu K, Mazieres J, et al. (2004) Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cell. Oncogene 23: 6170-6174.
6. Winn RA, Marek L, Han SY, Rodriguez K, Rodriguez N, et al. (2005) Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation. J Biol Chem 280: 19625-19634.
7. Uematsu K, He B, You L, Xu Z, McCormick F, et al. (2003) Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 22: 7218-7221.
8. Nozaki I, Tsuji T, Iijima O, Ohmura Y, Andou A, et al. (2001) Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer. Int J Oncol 19: 117-121.
9. Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, et al. (2003) WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol 201: 204-212.
10. Mazieres J, He B, You L, Xu Z, Lee AY, et al. (2004) Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 64: 4717-4720.
11. Lee AY, He B, You L, Dadfarmay S, Xu Z, et al. (2004) Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 23: 6672-6676.
12. Taki M, Kamata N, Yokoyama K, Fujimoto R, Tsutsumi S, et al. (2003) Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Cancer Sci 94: 593-597.
13. Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, et al. (2005) Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs 179: 56-65.
14. Sunaga N, Kohno T, Kolligs FT, Fearon ER, Saito R, et al. (2001) Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma. Genes Chromosomes Cancer 30: 316-321.
15. Ueda M, Gemmill RM, West J, Winn R, Sugita M, et al. (2001) Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 85: 64-68.
16. Blanco D, Vicent S, Elizegi E, Pino I, Fraga MF, et al. (2004) Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis. Lab Invest 84: 999-1012.
17. Akiri G, Cherian MM, Vijayakumar S, Liu G, Bafico A, et al. (2009) Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma. Oncogene 28: 2163-2172.
18. Hu Y, Galkin AV, Wu C, Reddy V, Su AI, (2011) CAFET algorithm reveals Wnt/PCP signature in lung squamous cell carcinoma. PLoS One 6: e25807.
19. Lockwood WW, Chari R, Coe BP, Thu KL, Garnis C, et al. (2010) Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma. PLoS Med 7: e1000315.
20. Bovia F, Salmon P, Matthes T, Kvell K, Nguyen TH, et al. (2003) Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors. Blood 101: 1727-1733.
21. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y, (2001) The new World Health Organization classification of lung tumours. Eur Respir J 18: 1059-1068.
22. Brandon C, Eisenberg LM, Eisenberg CA, (2000) WNTsignaling modulates the diversification of hematopoietic cells. Blood 96: 4132-4141.
23. Medrek C, Landberg G, Andersson T, Leandersson K, (2009) Wnt-5a-CKI{alpha} signaling promotes {beta}-catenin/E-cadherin complex formation and intercellular adhesion in human breast epithelial cells. J Biol Chem 284: 10968-10979.
24. Arnsdorf EJ, Tummala P, Jacobs CR, (2009) Non-canonical Wnt signaling and N-cadherin related beta-catenin signaling play a role in mechanically induced osteogenic cell fate. PloS One 4: e5388.
25. Danielson KG, Cohen IR, Huebner K, Nicholls JM, Iozzo RV, (1995) Characterization of the complete genomic structure of the human WNT-5A gene, functional analysis of its promoter, chromosomal mapping, and expression in early human embryogenesis. J Biol Chem 270: 31225-31234.
26. Nguyen DX, Chiang AC, Zhang XH-F, Kim JY, Kris MG, et al. (2009) WNT/TCF signaling through LEF1and HOXB9 mediates lung adenocarcinoma metastasis. Cell 138: 1-12.
27. Vuga LJ, Ben-Yehudah A, Kovkarova-Naumovski E, Oriss T, Gibson KF, et al. (2009) WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Am J Respir Cell Mol Biol 41: 583-589.
28. Hussain M, Rao M, Humphries AE, Hong JA, Liu F, et al. (2009) Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells. Cancer Res 69: 3570.
29. Kim GH, Her JH, Han JK, (2008) Ryk cooperates with Frizzled 7 to promote Wnt11-mediated endocytosis and is essential for Xenopus laevis convergent extension movements. J Cell Biol 182: 1073-1082.
30. Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, et al. (2007) The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem 282: 17259-17271.
31. Iioka H, Iemura S, Natsume T, Kinoshita N, (2007) Wnt signalling regulates paxillin ubiquitination essential for mesodermal cell motility. Nat Cell Biol 9: 813-821.
32. Pourreyron C, Reilly L, Proby C, Panteleyev A, Fleming C, et al. (2012) Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed. PLoS One 7: e31827.
33. Weidenfeld J, Shu W, Zhang I, Millar SE, Morrisey EE, (2002) The Wnt7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium. J Biol Chem 277: 21061-21070.
34. Shu W, Jiang YQ, Lu MM, Morrisey EE, (2002) Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 129: 4831-4842.
35. Kawasaki A, Torii K, Yamashita Y, Nishizawa K, Kanekura K, et al. (2007) Wnt5a promotes adhesion of human dermal fibroblasts by triggering a phosphatidylinositol-3 kinase/Akt signal. Cell Signal 19: 2498-2506.
36. Carmon KS, Loose DS, (2008) Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells. Mol Cancer Res 6: 1017-1028.
37. Kawakami Y, Wada N, Nishimatsu S, Nohno T, (2000) Involvement of frizzled-10 in Wnt-7a signaling during chick limb development. Dev Growth Differ 42: 561-569.
38. Wang Z, Shu W, Lu MM, Morrisey EE, (2005) Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5. Mol Cell Biol 25: 5022-5030.
39. Yuan G, Regel I, Lian F, Friedrich T, Hitkova I, et al. (2013) WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells. Oncogene 32: 375-387.
40. Kang MI, Baker AR, Dextras CR, Cabarcas SM, Young MR, et al. (2012) Targeting of Noncanonical Wnt5a Signaling by AP-1 Blocker Dominant-Negative Jun When It Inhibits Skin Carcinogenesis. Genes Cancer 3: 37-50.
41. Tichelaar JW, Yan Y, Tan Q, Wang Y, Estensen RD, et al. (2010) A dominant-negative c-jun mutant inhibits lung carcinogenesis in mice. Cancer Prev Res 3: 1148-1156.